demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
convalescent plasma treatment Libster

1 studies excluded by filtering options 0

5698 PLACID, 2020 113high risk of bias